AstraZeneca's expenditure on research and development 2006-2019

This statistic illustrates AstraZeneca's expenditure on research and development from 2006 to 2019. In 2019, AstraZeneca spent some 6 billion U.S. dollars on R&D. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.

AstraZeneca's expenditure on research and development from 2006 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2020

Region

Worldwide

Survey time period

2006 to 2019

Supplementary notes

Figures for 2006-2014 were taken from previous annual reports.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.